ENDO 2016: Women’s Health – Part 2

April 27, 2016

To continue our coverage of women’s health from ENDO 2016, we summarize findings on bone mass loss and asthma in polycystic ovary syndrome.

In the second half of this update on women’s health from ENDO 2016, Arun Karlamangla, University of California, Los Angeles presents his group’s work on a new assay to measure anti-Mullerian hormone as a potential means to predict bone density loss during trans-menopause. We also look at a possible link between asthma and polycystic ovary syndrome, discussed by Anju Joham, Monash University, Melbourne, Australia.